Connect with us
European Gaming Congress 2024

Fintech PR

Mutual Fund Assets Market Size to Grow USD 97158 Million by 2029 at a CAGR of 8.29% | Valuates Reports




BANGALORE, India, Nov. 23, 2023 /PRNewswire/ — Mutual Fund Assets Market is Segmented by Type (Equity Funds, Bond Funds, Money Market Funds), by Application (Financial Advisors, Banks, Direct Sellers): Global Opportunity Analysis and Industry Forecast, 2023-2029.

The global Mutual Fund Assets market was valued at USD 60258 Million in 2023 and is anticipated to reach USD 97158 Million by 2029, witnessing a CAGR of 8.29% during the forecast period 2023-2029.

Get Free Sample: 

Major Factors Driving the Growth of the Mutual Fund Assets Market:

The growing interest in mutual funds, which allow both large and small fund savers to take part in investment plans, is contributing significantly to the market’s expansion. The development of the mutual fund assets market is also fueled by the use of digital technology, ease, and fair pricing in terms of investments, and sophisticated portfolio management services. Furthermore, mutual fund companies have a lot of opportunities to grow and improve their current portfolio with more inexpensive and superior returns on investments in growing economies. Furthermore, during the projected period, governments are anticipated to offer profitable changes in response to their enhanced support and new efforts for the mutual fund assets market.


Buy Now with 10% Discount: 


Mutual fund assets grow as a result of both market success and the overall state of the economy. Investor participation in the financial markets is higher during times of economic expansion and favorable market circumstances, which results in more mutual fund investments. As investors look for ways to build wealth, positive economic indicators like a growing GDP, low unemployment rates, and favorable corporate profitability foster an atmosphere that is favorable for mutual fund growth. The rise of Mutual Fund Assets has been largely driven by continuous efforts to improve investor knowledge and education. Investors are more likely to devote their assets to mutual funds when they gain knowledge about the advantages of mutual funds, such as accessibility, professional fund management, and diversity.

The focus on long-term wealth accumulation and retirement planning has been a major factor in the rise of mutual fund assets. Due to their potential for long-term income production and capital appreciation, mutual funds present an alluring investment vehicle as more people realize how important it is to plan for their financial future. Retirement-focused funds, such as target-date funds and pension plans, contribute to the continued expansion of assets within the mutual fund sector.

Investors now have easier access to mutual funds because of technology improvements in fund distribution, such as mobile applications and Internet platforms. The accessibility of mutual fund investments has increased due to the ease of online transactions, real-time information, and user-friendly interfaces. The rise of mutual fund assets has been facilitated by the smooth integration of technology into fund distribution, which has increased the accessibility of investment possibilities for a wider range of investors.


The confidence that investors have in mutual fund investments has been greatly enhanced by regulatory reforms and investor protection measures. Trust among investors is bolstered by strong regulatory frameworks that guarantee responsibility, transparency, and disclosure. The implementation of regulatory measures with the objective of protecting investor interests and advancing equitable practices in the mutual fund sector elevates the general reputation of these investment vehicles, drawing in additional capital and augmenting the amount of assets under administration.

View Full Report: 


The financial industry in the area is well-established and mature, and mutual fund companies and asset management firms are widely distributed. Many investors, both institutional and retail, are drawn to the depth and breadth of the North American financial sector and trust mutual funds as their preferred investment vehicle. Furthermore, a high degree of financial knowledge and an investment culture are present in North America. Investors in the region are knowledgeable and actively look for ways to increase their wealth; mutual funds are a common option.

Get Regional Report: 


Key Players:

  • BlackRock
  • BNP Paribas Mutual Fund
  • Capital Group
  • Citigroup Inc.
  • Goldman Sachs
  • JPMorgan Chase& Co.
  • Morgan Stanley
  • State Street Corporation
  • The Vanguard Group

Buy Chapters:


We have introduced a tailor-made subscription for our customers. Please leave a note in the Comment Section to know about our subscription plans.


–  Mutual Funds Sales Market


–  Index Fund Market

–  Fund Investment Advisory Market

–  Investment Fund Service Market

–  Emerging Market Funds Market

–  Quantitative Investment Market


–  Asset Investment Planning Solutions Market

–  Fund Management Fee market is projected to reach USD 12410 million in 2029, increasing from USD 8927.3 million in 2022, with the CAGR of 4.5% during the period of 2023 to 2029.

–  Qualified Domestic Institutional Investor Market

–  Commercial Real Estate Equity Investment Market

–  Listed Open-end Fund (LOF) Market


–  The global investment banking & trading services market size was valued at USD 267,864.0 million in 2019, and is projected to reach USD 520,026.0 million by 2027, growing at a CAGR of 5.8% from 2020 to 2027.

–  Fund Management Fee market is projected to reach USD 12410 million in 2029, increasing from USD 8927.3 million in 2022, with the CAGR of 4.5% during the period of 2023 to 2029.

–  Fund of Funds (FOF) Market

–  Closed-End Funds Market

–  Exchange-Traded Fund Market


–  Multi-manager Investment Market

–  Variable life Insurance Market

–  Account Aggregators Market

–  E-brokerage Market

–  Finance Shared Service Market


–  Online Fundraising Software Market

–  Trade Finance market was valued at USD 8483660 million in 2022 and is anticipated to reach USD 11631260 million by 2029, witnessing a CAGR of 5.4% during the forecast period 2023-2029.

–  Microfinance market size is projected to reach USD 414980 million by 2028, from USD 184250 million in 2021, at a CAGR of 12.1% during 2022-2028.

–  The global fintech market size is projected to reach USD 16652680 million by 2028 from USD 6588780 million in 2021 at a Compound Annual Growth Rate (CAGR) of 13.9% during the forecast period 2022-2028.

–  The global financial guarantee market size was valued at USD 28.70 billion in 2020 and is projected to reach USD 71.93 billion by 2030, growing at a CAGR of 9.6% from 2021 to 2030.



Valuates offers in-depth market insights into various industries. Our extensive report repository is constantly updated to meet your changing industry analysis needs.

Our team of market analysts can help you select the best report covering your industry. We understand your niche region-specific requirements and that’s why we offer customization of reports. With our customization in place, you can request for any particular information from a report that meets your market analysis needs.

To achieve a consistent view of the market, data is gathered from various primary and secondary sources, at each step, data triangulation methodologies are applied to reduce deviance and find a consistent view of the market. Each sample we share contains a detailed research methodology employed to generate the report. Please also reach our sales team to get the complete list of our data sources.



Valuates Reports
[email protected]
For U.S. Toll-Free Call 1-(315)-215-3225
WhatsApp: +91-9945648335


Cision View original content:–valuates-reports-301996770.html

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Fintech PR

Invitation to presentation of EQT AB’s Q1 Announcement 2024




STOCKHOLM, April 5, 2024 /PRNewswire/ — EQT AB’s Q1 Announcement 2024 will be published on Thursday 18 April 2024 at approximately 07:30 CEST. EQT will host a conference call at 08:30 CEST to present the report, followed by a Q&A session.

The presentation and a video link for the webcast will be available here from the time of the publication of the Q1 Announcement.

To participate by phone and ask questions during the Q&A, please register here in advance. Upon registration, you will receive your personal dial-in details.

The webcast can be followed live here and a recording will be available afterwards.

Information on EQT AB’s financial reporting


The EQT AB Group has a long-term business model founded on a promise to its fund investors to invest capital, drive value creation and create consistent attractive returns over a 5 to 10-year horizon. The Group’s financial model is primarily affected by the size of its fee-generating assets under management, the performance of the EQT funds and its ability to recruit and retain top talent.

The Group operates in a market driven by long-term trends and thus believes quarterly financial statements are less relevant for investors. However, in order to provide the market with relevant and suitable information about the Group’s development, EQT publishes quarterly announcements with key operating numbers that are relevant for the business performance (taking Nasdaq’s guidance note for preparing interim management statements into consideration). In addition, a half-year report and a year-end report including financial statements and further information relevant for investors is published. Finally, EQT also publishes an annual report including sustainability reporting.

Olof Svensson, Head of Shareholder Relations, +46 72 989 09 15
EQT Shareholder Relations, [email protected]

Rickard Buch, Head of Corporate Communications, +46 72 989 09 11
EQT Press Office, [email protected], +46 8 506 55 334

This information was brought to you by Cision


The following files are available for download:

Invitation to presentation of EQT AB’s Q1 Announcement 2024,c3285895


EQT AB Group


View original content:

Continue Reading

Fintech PR

Kia presents roadmap to lead global electrification era through EVs, HEVs and PBVs



  • Kia drives forward transformation into ‘Sustainable Mobility Solutions Provider’
  • Roadmap enables Kia to proactively respond to uncertainties in mobility industry landscape, including changes in EV market
  • Company to expand EV line-up with more models; enhance HEV line-up to manage fluctuation in EV demand
    • Goal to sell 1.6 million EVs annually in 2030, introducing 15 models
    • PBV to play a key role in Kia’s growth, targeting 250,000 PBV sales annually by 2030 with PV5 and PV7 models
  • Kia to invest KRW 38 trillion by 2028, including KRW 15 trillion for future business
  • 2024 business guidance : KRW 101 tln in revenue with KRW 12 tln in operating profit; operating profit margin of 11.9% on sales of 3.2 million units globally
  • CEO reaffirms Kia’s commitment to ESG management

SEOUL, South Korea, April 5, 2024 /PRNewswire/ — Kia Corporation (Kia) today shared an update on its future strategies and financial targets at its CEO Investor Day in Seoul, Korea.

Based on its innovative achievements in the years since the announcement of mid-to-long-term business initiatives, Kia is focusing on updating its 2030 strategy announced last year and further strengthening its business strategy in response to uncertainties across the global mobility industry landscape.

During the event, Kia updated its mid-to-long-term business strategy with a focus on electrification, and its PBV business. Kia reiterated its 2030 annual sales target of 4.3 million units, including 1.6 million units of electric vehicles (EVs). The 2030 4.3 million annual sales target is 34.4 percent higher than the brand’s 2024 annual goal of 3.2 million units.

The company also plans to become a leading EV brand by selling a higher percentage of electrified models among its total sales, including hybrid electric vehicles (HEV), plug-in hybrid (PHEV), and battery EVs, projecting electrified model sales of 2.48 million units annually or 58 percent of Kia’s total sales in 2030.

“Following our successful brand relaunch in 2021, Kia is enhancing its global business strategy to further the establishment of an innovative EV line-up and accelerate the company’s transition to a sustainable mobility solutions provider,” said Ho Sung Song, President and CEO of Kia. “By responding effectively to changes in the mobility market and efficiently implementing mid-to-long-term strategies, Kia is strengthening its brand commitment to the wellbeing of customers, communities, the global society, and the environment.”


Photo –

Cision View original content to download multimedia:

Continue Reading

Fintech PR

BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update




VANCOUVER, BC, April 4, 2024 /PRNewswire/ — BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the “Company“) is providing this bi-weekly update on the status of the management cease trade order granted on February 29, 2024 (the “MCTO“), by its principal regulator, the Ontario Securities Commission (the “OSC“), under National Policy 12-203 – Management Cease Trade Orders (“NP 12-203“), following the Company’s announcement on February 21, 2024 (the “Default Announcement“), that it was unable to file its audited annual financial statements for the year ended October 31, 2023, its management’s discussion and analysis of financial statements for the year ended October 31, 2023, its annual information form for the year ended October 31, 2023, and related filings (collectively, the “Required Annual Filings“). Under National Instrument 51-102, the Required Annual Filings were required to be made no later than February 28, 2024.

As a result of the delay in filing the Required Annual Filings, the Company was unable to file its interim financial statements for the three months ended January 31, 2024, its management’s discussion and analysis of financial statements for the three months ended January 31, 2024, and related filings (collectively, the “Required Interim Filings“). Under National Instrument 51-102, the Required Interim Filings were required to be made no later than April 1, 2024.

The Company anticipates filing the Required Annual Filings by April 30, 2024. The auditor of the Company requires additional time to complete its audit of the Company, including the Company’s recent acquisition of all intellectual property, immunotherapeutics platform technologies, and clinical stage assets of the former IMV Inc. that closed on February 16, 2024. In addition, the Company anticipates filing the Required Interim Filings immediately after the filing of the Required Annual Filings.

Except as herein disclosed, there are no material changes to the information contained in the Default Announcement. In addition, (i) the Company is satisfying and confirms that it intends to continue to satisfy the provisions of the alternative information guidelines under NP 12-203 and issue bi-weekly default status reports for so long as the delay in filing the Required Annual Filings and/or Required Interim Filings is continuing, each of which will be issued in the form of a press release; (ii) the Company does not have any information at this time regarding any anticipated specified default subsequent to the default in filing the Required Annual Filings and Required Interim Filings; (iii) the Company is not subject to any insolvency proceedings; and (iv) there is no material information concerning the affairs of the Company that has not been generally disclosed.

About BioVaxys Technology Corp.


BioVaxys Technology Corp. (, a biopharmaceuticals company registered in British Columbia, Canada, is a clinical-stage biopharmaceutical company dedicated to improving patient lives with novel immunotherapies based on the DPX™ immune-educating technology platform and it’s HapTenix© ‘neoantigen’ tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization, and other immunological fields. The Company’s clinical stage pipeline includes maveropepimut-S which is in Phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using it proprietary HapTenix© ‘neoantigen’ tumor cell construct platform which is soon to enter Phase I in Spain for treating refractive late-stage ovarian cancer. The Company is also capitalizing on its tumor immunology know-how and creation of a unique library of T-lymphocytes & other datasets post-vaccination with its personalized immunotherapeutic vaccines to utilize predictive algorithms and other technologies to identify new targetable tumor antigens. BioVaxys common shares are listed on the CSE under the stock symbol “BIOV” and trade on the Frankfurt Bourse (FRA: 5LB) and in the US (OTCQB: BVAXF). For more information, visit and connect with us on X and LinkedIn.


Signed “James Passin
James Passin, Chief Executive Officer
Phone: +1 646 452 7054

Logo –

Cision View original content:

Continue Reading